Integrated Nanotherapeutics Inc. is an active federal corporation (corporation number 9116354). Its business number is 824601991. It was formed on Dec 10, 2014 under the Canada Business Corporations Act and its registered office is in Vancouver, British Columbia. Its annual returns are up to date, most recently for 2025. It has three directors on record.
Corporate details
- Corporation number
- 9116354
- Business number
- 824601991
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Formed
- Dec 10, 2014
- Registered office
- 1800 - 510 West Georgia Street
Vancouver BC V6B 0M3 - Number of directors
- At least 1, at most 5As the articles allow.
Annual filings
- Anniversary date
- Dec 10The date of incorporation, amalgamation or continuance.
- Annual filing period
- Dec 10 to Feb 8 each year
- Last annual meeting
- Jun 30, 2025
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Not yet due Due from Dec 10, 2026 | |
| 2025 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
11 agreements since 2018, worth $1,515,770 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | Integrated Nanotherapeutics Inc.-2026-2027-1045749 | $34,000 | Jun 10, 2026 |
| National Research Council Canada | Development of INT-101 formulation for human dosing and prevention of diabetes | $379,022 | Feb 10, 2026 |
| National Research Council Canada | Evaluation of a tolerogenic LNP (lipid nanoparticle) formulation to treat type 1 diabetes in a mouse model of type 1 diabetes | $506,250 | Apr 15, 2024 |
| National Research Council Canada | ICAP 2022 – International Co-Innovation Action Plan | $50,000 | Apr 1, 2023 |
| Global Affairs Canada | CIIP PDA – Integrated Nanotherapeutics Inc.– 2022-23 | $4,166 | Oct 21, 2022 |
| National Research Council Canada | Development of tolerogenic lipid nanoparticle (LNP) formulation containing messenger ribonucleic acid (mRNA) | $77,176 | Oct 16, 2021 |
| National Research Council Canada | Youth - Research Associate, Formulations | $36,000 | Jun 1, 2020 |
| National Research Council Canada | Lipid nanoparticle drugs for immunomodulatory therapy of autoimmune/inflammatory disease | $193,456 | Dec 16, 2019 |
| Global Affairs Canada | CXI - Integrated Nanotherapeutics Inc. 2019-2020 | $4,140 | Sep 9, 2019 |
| Western Economic Diversification Canada | 000015350 | $100,000 | Mar 19, 2019 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. The 10 most recent are shown. Search every federal grant.
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.